Although ALDH1, CD133, Oct3/4, and Sox2 have been identified as a putative marker for cancer stem cells in many cancers including HNSCC, we did not find a significant difference of these genes between CD24+/CD44+ and CD24-/CD44+ cell populations. The gene discussed is SOX2; the disease is cancer.